
"The company would also strategically look at in-licensing opportunities, alliances and partnerships to enhance its capabilities and product portfolio, gaining further legroom for growth in the US market," Alkem Laboratories said in its Annual Report for 2020-21.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ilMJjv
via
IFTTT
0 comments:
Post a Comment